Behm, D. J., Stankus, G., Doe, C. P. A., Willette, R. N., Sarau, H. M., Foley, J. J., . . . Douglas, S. A. (2006). The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Nature Publishing Group.

Behm, David J., et al. The Peptidic Urotensin-II Receptor Ligand GSK248451 Possesses Less Intrinsic Activity Than the Low-efficacy Partial Agonists SB-710411 and Urantide in Native Mammalian Tissues and Recombinant Cell Systems. Nature Publishing Group, 2006.

Behm, David J., et al. The Peptidic Urotensin-II Receptor Ligand GSK248451 Possesses Less Intrinsic Activity Than the Low-efficacy Partial Agonists SB-710411 and Urantide in Native Mammalian Tissues and Recombinant Cell Systems. Nature Publishing Group, 2006.